Haemonetics (HAE) Gross Margin Growth (1y) (2010 - 2026)

Haemonetics (HAE) Gross Margin Growth (1y) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (1y) (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -67.00
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -54.00
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 60.00
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 62.00
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -65.00
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 610.00
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 9.00
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -359.00
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Haemonetics 3.50 Bn 3.26 Bn 198.21 Mn -117.00

Historic Data

Download Data
DateValue
Mar 28, 2026 -117.00
Dec 27, 2025 418.00
Sep 27, 2025 525.00
Jun 28, 2025 778.00
Mar 29, 2025 715.00
Dec 28, 2024 263.00
Sep 28, 2024 66.00
Jun 29, 2024 -169.00
Mar 30, 2024 -9.00
Dec 30, 2023 91.00
Sep 30, 2023 52.00
Jul 1, 2023 -69.00
Apr 1, 2023 -11.00
Dec 31, 2022 -136.00
Oct 1, 2022 199.00
Jul 2, 2022 712.00
Apr 2, 2022 1,508.00
Jan 1, 2022 331.00
Oct 2, 2021 60.00
Jul 3, 2021 126.00